StockData
ENVBNasdaqPharmaceutical PreparationsFiscal year ends December 31

Enveric Biosciences, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.39+0.01 (+0.72%)

Close on Oct 19, 2026

Market cap
$5.54M
P/E (TTM)
–
Dividend yield
–

Enveric Biosciences, Inc. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Enveric Biosciences does not break out revenue by segment, region or product in the tagged data of its filings for this period type.